USP39 promotes tumorigenesis by stabilizing and deubiquitinating SP1 protein in hepatocellular carcinoma

被引:28
|
作者
Dong, Xiao [1 ]
Liu, Zixin [2 ]
Zhang, Encheng [3 ]
Zhang, Pingzhao [4 ]
Wang, Yuqi [4 ]
Hang, Junjie [4 ]
Li, Qi [1 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Oncol, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China
[2] Second Mil Med Univ, Dept Hepatobiliary Pancreat Surg, Changhai Hosp, Navy Mil Med Univ, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Urol, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China
[4] Nanjing Med Univ, Dept Oncol, Changzhou 2 Peoples Hosp, Affiliated Hosp, Changzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; USP39; SP1; De-ubiquitination; Proliferation; CANCER; GROWTH; METASTASIS; CELLS;
D O I
10.1016/j.cellsig.2021.110068
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Deubiquitinating enzyme (DUB) can hydrolyze ubiquitin molecules from the protein bound with ubiquitin, and reversely regulate protein degradation. The ubiquitin-specific proteases (USP) family are cysteine proteases, which owns the largest members and diverse structure among the currently known DUB. The important roles of ubiquitin-specific peptidase39 (USP39) in cancer have been widely investigated. However, little is known about the putative de-ubiquitination function of USP39 in hepatocellular carcinoma (HCC) and the mechanisms of USP39 regulating tumor growth. Here, we used bioinformatics methods to reveal that USP39 expression is significantly upregulated in several cancer database. High expression of USP39 is correlated with poor prognosis of HCC patients. Then, we identify the specificity protein 1 (SP1), as a novel subtract of the USP39. We observe that USP39 stabilizes SP1 protein and prolongs its half-life by promoting its deubiquitylation pathway. In addition, our results show USP39 promotes cell proliferation by SP1-depenet manner in vivo and vitro. Knocking down of USP39 promotes the cell apoptosis and arrest of the cell cycle, whereas SP1 forcefully reversed these effects. Taken together, our results suggest that USP39 participates the deubiquitylation of SP1 protein, providing new pathway for understand the upstream signaling for oncogene SP1.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Succinylation modification-mediated upregulation of Sp1 promotes hepatocellular carcinoma cell proliferation
    Han, Yehong
    Deng, Xueqin
    Chen, Haixia
    Chen, Jie
    Xu, Wei
    Liu, Lanqin
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [32] USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
    Meng, Jing
    Ai, Xiaoyu
    Lei, Yueyang
    Zhong, Weilong
    Qian, Baoxin
    Qiao, Kailiang
    Wang, Xiaorui
    Zhou, Bijiao
    Wang, Hongzhi
    Huai, Longcong
    Zhang, Xiaoyun
    Han, Jingxia
    Xue, Yinyin
    Liang, Yuan
    Zhou, Honggang
    Chen, Shuang
    Sun, Tao
    Yang, Cheng
    THERANOSTICS, 2019, 9 (02): : 573 - 587
  • [33] USP22 promotes angiotensin II-induced podocyte injury by deubiquitinating and stabilizing HMGB1
    Peng, Zhuan
    Huang, Xiaoxiao
    Pan, Yangbin
    Li, Weiwei
    Hu, Hongtu
    Chen, Xinghua
    Zhang, Zongwei
    Hu, Jijia
    Qi, Yue
    Chen, Wenjie
    Cui, Xiaofei
    Liu, Hongyan
    Liang, Wei
    Ding, Guohua
    Chen, Zhaowei
    CELLULAR SIGNALLING, 2025, 131
  • [34] Deubiquitinase USP28 promotes the malignant progression and radio-resistance of hepatocellular carcinoma by stabilizing WDHD1
    Wen, Wu
    Zhou, Zhenhua
    Chen, Chao
    Chen, Ming
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [35] SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation
    Su, Chen
    Zhang, Haoquan
    Mo, Jie
    Liao, Zhibin
    Zhang, Bixiang
    Zhu, Peng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (01):
  • [36] Elevated expression of Erbin destabilizes ERα protein and promotes tumorigenesis in hepatocellular carcinoma
    Wu, Hua
    Yao, Su
    Zhang, Shen
    Wang, Jing-Ru
    Guo, Peng-Da
    Li, Xiu-Ming
    Gan, Wen-Juan
    Mei, Lin
    Gao, Tian-Ming
    Li, Jian-Ming
    JOURNAL OF HEPATOLOGY, 2017, 66 (06) : 1193 - 1204
  • [37] GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis
    Amann, T.
    Maegdefrau, U.
    Kreuz, M.
    Hartmann, A.
    Schoelmerich, J.
    Bosserhoff, A. K.
    Hellerbrand, C.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S126 - S126
  • [38] GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
    Amann, Thomas
    Maegdefrau, Ulrike
    Hartmann, Arndt
    Agaimy, Abbas
    Marienhagen, Joerg
    Weiss, Thomas S.
    Stoeltzing, Oliver
    Warnecke, Christina
    Schoelmerich, Juergen
    Oefner, Peter J.
    Kreutz, Marina
    Bosserhoff, Anja K.
    Hellerbrand, Claus
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (04): : 1544 - 1552
  • [39] FAT1 EXPRESSION IS INCREASED IN HEPATOCELLULAR CARCINOMA AND PROMOTES TUMORIGENESIS
    Valletta, D.
    Czech, B.
    Weiss, T. S.
    Bosserhoff, A.
    Hellerbrand, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S129 - S129
  • [40] USP27 promotes glycolysis and hepatocellular carcinoma progression by stabilizing PFKFB3 through deubiquitination
    Xie, Longhui
    Song, Dekun
    Ouyang, Zhengsheng
    Ning, Yinkuan
    Liu, Xintao
    Li, Lai
    Xia, Wangning
    Yang, Yang
    CELLULAR SIGNALLING, 2025, 127